Payment overview · 2025
General Payments
$118.71
6 reported records · 6 companies
Healthcare provider profile · identity verified
Catherine A Bishop, DO
Allopathic & Osteopathic Physicians|Family Medicine · CHILLICOTHE, OH · NPI 1932123296
Verified facts
What the public records show
CMS Open Payments records show Catherine A Bishop, DO received $118.71 in general payments during 2025 across 6 reported records.
Exact Sciences Corporation accounted for 22.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 96 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $27.09 | 22.8% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $25.43 | 21.4% | 1 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $20.41 | 17.2% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $17.78 | 15.0% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $14.52 | 12.2% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $13.48 | 11.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $118.71 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $27.09 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $25.43 | 1 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $20.41 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $17.78 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Lilly USA, LLC | $14.52 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $13.48 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $13.48 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 96 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
96 | 21 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 889 | 170 |
| Furosemide | Furosemide | 731 | 106 |
| Levothyroxine Sodium | Levothyroxine Sodium | 678 | 103 |
| Eliquis | Apixaban | 616 | 65 |
| Lisinopril | Lisinopril | 424 | 88 |
| Omeprazole | Omeprazole | 418 | 95 |
| Gabapentin | Gabapentin | 402 | 75 |
| Amlodipine Besylate | Amlodipine Besylate | 393 | 108 |
| Potassium Chloride | Potassium Chloride | 383 | 70 |
| Sertraline Hcl | Sertraline Hcl | 359 | 64 |
| Metoprolol Tartrate | Metoprolol Tartrate | 341 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 329 | 73 |
| Donepezil Hcl | Donepezil Hcl | 300 | 37 |
| Famotidine | Famotidine | 252 | 48 |
| Mirtazapine | Mirtazapine | 240 | 48 |
| Trazodone Hcl | Trazodone Hcl | 231 | 55 |
| Allopurinol | Allopurinol | 209 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 205 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 203 | 41 |
| Tramadol Hcl | Tramadol Hcl | 194 | 36 |
| Buspirone Hcl | Buspirone Hcl | 181 | 37 |
| Prednisone | Prednisone | 177 | 47 |
| Losartan Potassium | Losartan Potassium | 172 | 51 |
| Oxycodone Hcl | Oxycodone Hcl | 164 | 26 |
| Memantine Hcl | Memantine Hcl | 159 | 26 |
| Alprazolam | Alprazolam | 156 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 147 | 24 |
| Metformin Hcl | Metformin Hcl | 146 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 142 | 33 |
| Carvedilol | Carvedilol | 141 | 30 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 138 | 24 |
| Lorazepam | Lorazepam | 135 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 131 | 27 |
| Pregabalin | Pregabalin | 123 | 15 |
| Levetiracetam | Levetiracetam | 120 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 118 | 24 |
| Sucralfate | Sucralfate | 118 | 15 |
| Nystatin | Nystatin | 115 | 49 |
| Latanoprost | Latanoprost | 113 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 110 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 108 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 105 | 21 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 105 | 45 |
| Warfarin Sodium | Warfarin Sodium | 98 | 13 |
| Cephalexin | Cephalexin | 97 | 38 |
| Montelukast Sodium | Montelukast Sodium | 97 | 17 |
| Clonazepam | Clonazepam | 96 | suppressed |
| Jardiance | Empagliflozin | 96 | 21 |
| Atenolol | Atenolol | 89 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 89 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 86 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 86 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 83 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 81 | 14 |
| Celecoxib | Celecoxib | 76 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 73 | 30 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 73 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 72 | 24 |
| Diclofenac Sodium | Diclofenac Sodium | 71 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 69 | 21 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 69 | 33 |
| Tizanidine Hcl | Tizanidine Hcl | 69 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 21 |
| Vancomycin Hcl | Vancomycin Hcl | 65 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 63 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 12 |
| Spironolactone | Spironolactone | 62 | 18 |
| Xarelto | Rivaroxaban | 62 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 34 |
| Bupropion Xl | Bupropion Hcl | 60 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 60 | 36 |
| Glimepiride | Glimepiride | 58 | 17 |
| Midodrine Hcl | Midodrine Hcl | 58 | 18 |
| Haloperidol | Haloperidol | 56 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 56 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 54 | 11 |
| Finasteride | Finasteride | 53 | suppressed |
| Azithromycin | Azithromycin | 49 | 28 |
| Meclizine Hcl | Meclizine Hcl | 48 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 46 | 11 |
| Baclofen | Baclofen | 46 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 46 | 16 |
| Primidone | Primidone | 46 | suppressed |
| Januvia | Sitagliptin Phosphate | 45 | suppressed |
| Olanzapine | Olanzapine | 45 | suppressed |
| Topiramate | Topiramate | 45 | suppressed |
| Rexulti | Brexpiprazole | 43 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 41 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 22 |
| Nifedipine Er | Nifedipine | 38 | suppressed |
| Digoxin | Digoxin | 37 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 37 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Ondansetron Odt | Ondansetron | 34 | 19 |
| Alendronate Sodium | Alendronate Sodium | 33 | 17 |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Diazepam | Diazepam | 32 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Lidocaine | Lidocaine | 32 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Tradjenta | Linagliptin | 32 | suppressed |
| Lamotrigine | Lamotrigine | 31 | suppressed |
| Lovastatin | Lovastatin | 31 | suppressed |
| Meloxicam | Meloxicam | 31 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 30 | 29 |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Fluconazole | Fluconazole | 29 | 20 |
| Methimazole | Methimazole | 29 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 28 | 16 |
| Azelastine Hcl | Azelastine Hcl | 27 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 26 | suppressed |
| Levofloxacin | Levofloxacin | 26 | 20 |
| Metformin Hcl Er | Metformin Hcl | 26 | 13 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Phenobarbital | Phenobarbital | 25 | suppressed |
| Simvastatin | Simvastatin | 25 | 11 |
| Zenpep | Lipase/Protease/Amylase | 25 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | 16 |
| Linzess | Linaclotide | 24 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Vraylar | Cariprazine Hcl | 24 | suppressed |
| Acetic Acid | Acetic Acid | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 21 | suppressed |
| Austedo | Deutetrabenazine | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Epogen | Epoetin Alfa | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 19 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 19 | suppressed |
| Klor-Con 10 | Potassium Chloride | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | 11 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 18 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 17 | suppressed |
| Calcium Acetate | Calcium Acetate | 17 | suppressed |
| Klayesta | Nystatin | 17 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Ertapenem | Ertapenem Sodium | 16 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 16 | 12 |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Tobramycin | Tobramycin | 15 | 11 |
| Verapamil Sr | Verapamil Hcl | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Amantadine | Amantadine Hcl | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Meropenem | Meropenem | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Modafinil | Modafinil | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 13 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $118.71 · 6 records | Exact Sciences Corporation | Cologuard Collection Kit, Dexcom G6 Transmitter, JARDIANCE, Kerendia, Korlym, Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error